Form D · Biotechnology
TopoDx, Inc.
Atlanta, GA · CIK 0002075590
Offering snapshot reported Sep 5, 2025 · SEC filing
- Reported sold
- $1.5M Offering amount: $2M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jul 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 5, 2025 | Amendment | $1,500,000 | No comparison | 10 | SEC filing |
| Jul 15, 2025 | Initial | $1,125,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-551780
Source: Form D, filed Sep 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yogi Patel | Director, Executive |
| David Weiss | Director |
| Peter Yunker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
101 Nerem St. Nw Suite 1000
Atlanta, GA, 30313
Atlanta, GA, 30313